Home LiteratureArticle Details
PMID: 11533182 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.

Journal of virology ·Vol. 75 ·No. 19 ·2001-10-00 ·Pages 9187-200

Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA

Abstract

Macrophages are thought to represent one of the first cell types in the body to be infected during the early stage of human immunodeficiency virus type 1 (HIV-1) transmission and represent a potential viral reservoir in vivo. Thus, an understanding of HIV-1 attachment to these cells is fundamental to the development of novel anti-HIV-1 therapies. Although one of the major targets of HIV-1 in vivo--CD4(+) T lymphocytes--express high CD4 levels, other major targets such as macrophages do not. We asked in this study whether this low CD4 level on macrophages is sufficient to support HIV-1 attachment to these cells or whether cell surface proteins other than CD4 are required for this process. We show that CD4 alone is not sufficient to support the initial adsorption of HIV-1 to macrophages. Importantly, we find that heparan sulfate proteoglycans (HSPGs) serve as the main class of attachment receptors for HIV-1 on macrophages. Most importantly, we demonstrate that a single family of HSPGs, the syndecans, efficiently mediates HIV-1 attachment and represents an abundant class of attachment receptors on macrophages.

MeSH Terms
HIV Infections/metabolism,virology HIV-1/physiology HeLa Cells Humans Macrophages/metabolism,virology Membrane Glycoproteins/physiology Proteoglycans/physiology Receptors, HIV/physiology Syndecans Virus Replication
Chemicals
Membrane Glycoproteins Proteoglycans Receptors, HIV Syndecans
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Saphire A C
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
Bobardt M D
Zhang Z
David G
Gallay P A
References (36)
36 references, click to expand
  1. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans.
    EMBO J. 1999 Dec 1;18(23):6771-85 PMID: 10581250
  2. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
    J Cell Biol. 1996 Apr;133(2):405-16 PMID: 8609172
  3. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.
    Cell. 2000 Mar 3;100(5):587-97 PMID: 10721995
  4. Functions of cell surface heparan sulfate proteoglycans.
    Annu Rev Biochem. 1999;68:729-77 PMID: 10872465
  5. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.
    J Virol. 2000 Sep;74(17):7824-33 PMID: 10933689
  6. CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.
    J Virol. 2000 Sep;74(18):8550-7 PMID: 10954556
  7. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
    Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):658-63 PMID: 11136236
  8. Generation of HIV latency during thymopoiesis.
    Nat Med. 2001 Apr;7(4):459-64 PMID: 11283673
  9. Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.
    Int J Cancer. 1977 Jan;19(1):136 PMID: 264472
  10. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.
    Science. 1986 Sep 5;233(4768):1089-93 PMID: 3016903
  11. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.
    Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089-93 PMID: 3018755
  12. Cell density-dependent expression of chondroitin sulfate proteoglycan in cultured human monocytes.
    J Biol Chem. 1988 Feb 15;263(5):2526-31 PMID: 3339020
  13. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus.
    J Infect Dis. 1988 Jul;158(1):193-9 PMID: 2839582
  14. Early HIV-1 infection and the AIDS dementia complex.
    Neurology. 1990 Feb;40(2):323-6 PMID: 2300258
  15. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    J Virol. 1991 Mar;65(3):1543-50 PMID: 1995952
  16. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4.
    J Virol. 1991 Jun;65(6):3276-83 PMID: 1709701
  17. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
    J Virol. 1992 Jan;66(1):235-43 PMID: 1727487
  18. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.
    J Virol. 1992 Jan;66(1):305-9 PMID: 1727490
  19. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1).
    J Clin Invest. 1992 Jan;89(1):176-83 PMID: 1370293
  20. Early viral brain invasion in iatrogenic human immunodeficiency virus infection.
    Neurology. 1992 Sep;42(9):1736-9 PMID: 1513462
  21. Virus receptors: binding, adhesion strengthening, and changes in viral structure.
    J Virol. 1994 Jan;68(1):1-5 PMID: 8254718
  22. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.
    Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6992-6 PMID: 8041734
  23. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.
    J Virol. 1995 Apr;69(4):2233-9 PMID: 7884870
  24. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
    J Exp Med. 1995 Jul 1;182(1):185-96 PMID: 7540648
  25. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression.
    AIDS Res Hum Retroviruses. 1995 Jul;11(7):769-76 PMID: 7546902
  26. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.
    J Virol. 1997 Apr;71(4):2779-85 PMID: 9060632
  27. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Nature. 1997 May 8;387(6629):183-8 PMID: 9144289
  28. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.
    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9825-30 PMID: 9275210
  29. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization.
    J Exp Med. 1997 Oct 20;186(8):1287-98 PMID: 9334368
  30. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans.
    J Immunol. 1997 Nov 1;159(9):4587-92 PMID: 9379060
  31. Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease.
    AIDS. 1997 Nov 15;11(14):1699-708 PMID: 9386804
  32. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.
    J Virol. 1998 May;72(5):3623-34 PMID: 9557643
  33. HIV. Envelope's letters boxed into shape.
    Nature. 1998 Jun 18;393(6686):630-1 PMID: 9641673
  34. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
    J Virol. 1999 May;73(5):3544-50 PMID: 10196243
  35. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action.
    J Biol Chem. 1999 Aug 20;274(34):24113-23 PMID: 10446183
  36. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.
    J Virol. 2000 Feb;74(4):1948-60 PMID: 10644368
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-10-00
Pages
9187-200
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114487
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com